ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Oral SQ House Dust Mite Immunotherapy Reduces Allergic Rhinitis Symptoms in Teens – Monthly Prescribing Reference (registration)

Oral SQ House Dust Mite Immunotherapy Reduces Allergic Rhinitis Symptoms in TeensMonthly Prescribing Reference (registration)The oral SQ house dust mite (HDM) sublingual immunotherapy (SLIT)-tablet, an allergy immunotherapy tablet, reduces house dust m… Continue reading

2017-03-04 Michael Zand NEWS

How Safe is Subcutaneous and Sublingual Allergen Immunotherapy? – Benzinga

Continue reading

2017-03-04 Michael Zand NEWS

Oral House Dust Mite Immunotherapy Safe, Effective in Allergic Rhinitis – Monthly Prescribing Reference (registration)

How Safe is Subcutaneous and Sublingual Allergen Immunotherapy?
Benzinga
The research was presented in the abstract “Evaluation of Risk Factors for Infections and Systemic Reactions (SRs) Associated with Subcutaneous and Sublingual Allergen Immunotherapy (SCIT and SLIT): AAAAI/ACAAI National Surveillance Study …

and more »

Continue reading

2017-03-04 Michael Zand NEWS

Stem cells offering faint cure possibility for glaucoma – ModernMedicine

Oral House Dust Mite Immunotherapy Safe, Effective in Allergic Rhinitis
Monthly Prescribing Reference (registration)
ATLANTA, GA—House dust mite (HDM) sublingual immunotherapy (SLIT) tablet (MK-8237, Merck/ALK) offers consistent efficacy and safety among patients with HDM allergic rhinitis, with or without conjunctivitis (AR/C), according to a post-hoc analysis of …

Continue reading

2017-03-04 Michael Zand NEWS

Dr. John Reitz: Preserving stem cells from baby teeth – Reading Eagle


Benzinga

Stem cells offering faint cure possibility for glaucoma
ModernMedicine
Atlanta — Stem cell technology may soon enter the mainstream as a treatment for ocular disease, says Leo Semes, OD, FAAO, at this year’s annual SECO 2017 conference. While stem cell therapy is not yet ready for human application, its advancement may …
Exclusive: CBMG CEO Talks Stem–Cell Therapies, Cancer Treatments, Financials & The Chinese MarketBenzinga
This simple method can predict a stem cell’s fate – FuturityFuturity: Research News
Stem cell treatment may restore vision to patients with damaged corneasScienceBlog.com (blog)
Diabetes.co.uk –Street Register –Medgadget (blog)
all 14 news articles »
Continue reading

2017-03-04 Michael Zand NEWS

Why does anybody own CRISPR? An argument against academic IP – MedCity News


Reading Eagle

Dr. John Reitz: Preserving stem cells from baby teeth
Reading Eagle
Dear Dr. Reitz: My dentist offers a service in which a child’s stem cells are obtained and saved from their baby teeth. The stem cells are frozen, with the potential to cure various systemic diseases that my child may have later in life. Do you know …

Continue reading

2017-03-04 Michael Zand NEWS

New Type Of Radiation Therapy Gives Hope For The Prevention Of Developing Second Cancer In Children – Latinos Health


MedCity News

Why does anybody own CRISPR? An argument against academic IP
MedCity News
“I’ve seen many examples, both in companies I’m associated with and other people, of people who could make use of CRISPR in very big and important ways, but are doing other things that are slower, more expensive, less efficient, because they are …

Continue reading

2017-03-04 Michael Zand NEWS

Advaxis, SELLAS Ink Licensing Agreement for WT1 Antigen-Targeting Immunotherapy – Drug Discovery & Development


Latinos Health

New Type Of Radiation Therapy Gives Hope For The Prevention Of Developing Second Cancer In Children
Latinos Health
This is a very effective form of radiotherapy; it utilizes a high-powered beam of protons in replace of the high-energy X-rays. It transported proper doses to the cancerous areas thus it doesn’t hit healthy tissues. Read also gene therapy for blood …

and more »

Continue reading

2017-03-04 Michael Zand NEWS
  • 1
  • …
  • 2,019
  • 2,020
  • 2,021
  • 2,022
  • 2,023
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Drug Discovery & Development

Advaxis, SELLAS Ink Licensing Agreement for WT1 Antigen-Targeting Immunotherapy
Drug Discovery & Development
Advaxis, Inc. and SELLAS Life Sciences Group, both late-stage biopharmaceutical companies focused on developing cancer immunotherapies, today announced that Advaxis has granted SELLAS a license to develop a novel cancer immunotherapy agent …